Devastating Disease finally gets International Attention

Trials are beginning on a new oral medication for a disease that threatens about 60 million people a year in 36 countries of sub-Saharan Africa.

An International research team is to commence clinical trials on a new treatment for trypanosomiasis, known as “Sleeping Sickness”.

The Phase III clinical trial starts this month. The new pivotal trial will involve approximately 250 patients in the Democratic Republic of the Congo and the Sudan. Angola will be included if a recent outbreak there of the Ebola-like Marburg virus remains under control.

The compound known as DB289 is the first new medication for the disease in 50 years, and the only oral medication that’s ever been developed. News of the trials was released by the University of North Carolina at Chapel Hill (UNC). UNC is the lead institution in the team which also includes researchers from Scotland, Kenya, England, and Switzerland.

Oral delivery of medication is important because the disease most frequently occurs in rural areas and villages not served by medical professionals capable of administering injections.

The Bill and Melinda Gates Foundation is supporting the work, led by Dr. Richard R. Tidwell, professor of pathology and laboratory medicine at the UNC School of Medicine.

There has been no research in this area by large pharmaceutical companies largely because of the lack of profit potential. A small pharmaceutical company, Immtech International is a contributor to this drug development effort.

“Despite being one of Africa’s most prevalent and economically devastating illnesses, sleeping sickness is definitely one of those that has been neglected,” Tidwell said. “For that reason, we decided to put this consortium together, and that’s why the Bill & Melinda Gates Foundation was very interested in supporting our work.”

DB289 has successfully undergone trials that have demonstrated its safety and effectiveness in patients with early-stage sleeping sickness. In the testing phase soon getting under way, scientists will give the treatment to hundreds of patients for the first time.

Sleeping sickness is passed from human to human by tsetse fly bites. The symptoms are fever, lymph node inflammation, impairment of the brain and nervous system in the late stages. It can lead to death without treatment.

The World Health Organization received reports of 45,000 cases of the disease in 1999. The agency says that most cases are occurring in areas where there is not reliable reporting on the occurrence of disease, and consequently estimates that the actual number of cases could be as much as 10 times higher.

Three years ago, the National Foundation for Infectious Diseases presented its Jimmy and Roselyn Carter Humanitarian Award to Bill and Melinda Gates. That day, a talk by former President Jimmy Carter about the work Roselyn and he did in Africa inspired Dr. Carol Olson, vice president and chief medical officer of Immtech, to work on deadly but neglected illnesses, she said.

Olson said “We have a real opportunity with DB289 and other drug candidates in the pipeline to help solve some very difficult health problems affecting millions of people in developing countries.”

Hot this week

Did David Wineland and Serge Haroche Steal Idea For The Nobel Physics Prize?

Dr. Omerbashich says the Royal Swedish Academy is a Crime Scene and he has the proof that Nobel laureates stole his discovery.

New Approaches to Disaster Relief Challenges

Disaster relief has always been a challenge. NASA, Google,...

3 Legitimate Money Making Methods to Supplement Your Income

In a perfect world, when your landlord raises your...

2016 Predictions by World Renowned Medium and Psychic Lindy Baker

World renowned medium and psychic Lindy Baker is interviewed by The Hollywood Sentinel, discussing psychic power, the spirit world, life after death, areas of concern in 2016, and much more.

Digital Coupon Customers Spending More Than Double At Stores

A new study shows that customers who use digital coupons go shopping more for groceries and other household goods more often and spend more on their shopping trips.

The Checkup Men Skip: What Testicular and Prostate Warning Signs Actually Look Like

Men are remarkably good at tolerating discomfort and remarkably bad at reporting it. Ask a urologist what the most common delay in genitourinary cancer care looks like, and the answer is rarely a diagnostic failure. It is a man who noticed

The Research Report Passed Review, but the Evidence Was Incomplete: Why Biotechnology Companies Need Stronger Scientific Audit Trails

A biotechnology company receives a laboratory report that appears to confirm a research finding. The figures are consistent, the document has been reviewed, and the reported result seems sufficient to support the next stage of an investigat

What to Expect at Your First Pointe Shoe Fitting

For all young dancers who take even a single...

The Insurer’s Nurse Followed You Into the Exam Room

You're on the paper-covered exam table waiting for the orthopedist when someone you've never met walks in behind the nurse. She introduces herself as the case manager assigned to your workers' compensation claim, takes the chair by the door

When the Second Assist Vanishes, Who Carries the Exposure?

A lumbar fusion requires more than the surgeon's hands. Retractors must maintain exposure, instruments need to move efficiently, and the team must respond when bleeding or difficult anatomy changes the operative plan. In some operating room

I Tested Stop Brain Clutter App’s Personalized Meditation System

Stop Brain Clutter takes a different approach to guided meditation. The app builds a personalized meditation from information you give it.

Israel, You Must Muster Unity

But what makes Israel particularly remarkable is the idea that unity does not require sameness.

Related Articles

Popular Categories